首页> 外文期刊>Transplant immunology >The cellular basis of cardiac allograft rejection. IX. Ratio of naive CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance.
【24h】

The cellular basis of cardiac allograft rejection. IX. Ratio of naive CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance.

机译:心脏同种异体排斥反应的细胞基础。九。原始CD4 + CD25 + T细胞/ CD4 + CD25-T细胞的比例决定了排斥或耐受性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Naive CD4+ T cells are central to allograft rejection, but include 3-10% CD4+CD25+ T cells that induce and maintain immune tolerance. Whether increasing the ratio of CD4+CD25+ T cells can inhibit rejection and induce tolerance is not known. This study examined the effects that naive CD4+CD25+ and CD4+CD25- T cells have on rejection of MHC incompatible PVG cardiac allografts in whole body irradiated DA rats. The ratio of CD4+CD25+ T cells to CD4+CD25- T cells was increased to examine if this delayed rejection. CD4+CD25- T cells alone restored near first set rejection time of 8-10 days and were significantly faster than unfractionated CD4+ T cells which nearly always took over 10 days to effect rejection. Enriched CD4+CD25+ T cells, either fresh or cultured with IL-2 and donor alloantigen, did not restore rejection. Admixing naive CD4+CD25+ T cells with CD4+ T cells at a ratio of 1:10 prevented graft destruction by rejection. Naive CD4+CD25+ T cells, either fresh or cultured with IL-2 and donor alloantigen, at a ratio of 1:1, prevented significant episodes of rejection and grafts survived >300 days. These grafts had large areas of normal myocardium but had some foci of CD4+, CD8+ and CD25+ cellular infiltration. This study found CD4+CD25- T cells were the principal mediators of rejection and naive CD4+CD25+ T cells partially inhibited the CD4+CD25- T cells in unfractionated CD4+ T cells. Increasing the ratio of naive CD4+CD25+ to CD4+CD25- T cells inhibited rejection allowing grafts to survive indefinitely and may induce transplant tolerance, without a need for long-term immunosuppression.
机译:幼稚的CD4 + T细胞是同种异体移植排斥的关键,但包括3-10%的CD4 + CD25 + T细胞,它们诱导并维持免疫耐受。增加CD4 + CD25 + T细胞的比例是否可以抑制排斥并诱导耐受性尚不清楚。这项研究检查了天然CD4 + CD25 +和CD4 + CD25- T细胞对全身照射的DA大鼠MHC不相容的PVG心脏异体移植排斥的影响。增加CD4 + CD25 + T细胞与CD4 + CD25-T细胞的比例,以检查这种延迟排斥。单独的CD4 + CD25-T细胞在最初设置的排斥时间8-10天附近恢复,并且比未分级的CD4 + T细胞几乎总要花10天以上的时间才能恢复。新鲜的或用IL-2和供体同种异体抗原培养的富含CD4 + CD25 + T细胞不能恢复排斥反应。原始的CD4 + CD25 + T细胞与CD4 + T细胞以1:10的比例混合可防止排斥反应导致移植物破坏。新鲜的CD4 + CD25 + T细胞(新鲜的或与IL-2和供体同种异体抗原按1:1比例培养的T细胞)可防止明显的排斥反应,并且移植物存活> 300天。这些移植物具有大面积的正常心肌,但有一些CD4 +,CD8 +和CD25 +细胞浸润灶。这项研究发现,CD4 + CD25-T细胞是排斥的主要介质,幼稚的CD4 + CD25 + T细胞部分抑制了未分离的CD4 + T细胞中的CD4 + CD25-T细胞。增加原始CD4 + CD25 +与CD4 + CD25-T细胞的比例可抑制排斥反应,使移植物无限期存活并可能诱导移植耐受,而无需长期的免疫抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号